Skip to content

Accuracy of Cell-Level Fluorescence Technology in Assessing Intervertebral Disc Degeneration during Lumbar Surgery

Diagnostic Accuracy of Cell-Level Fluorescence-Guided Technology (EndoSCell) for Evaluating Nucleus Pulposus Degeneration in Lumbar Discectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129609
Enrollment
Unknown
Registered
2026-08-06
Start date
2026-08-31
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation

Interventions

Gold Standard:Paraffin pathology examination (Hematoxylin and Eosin staining)
Index test:EndoSCell® Cell-Level Fluorescence-Guided Imaging System

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–70 years, any gender. 2.Preoperatively diagnosed with single-level, primary lumbar disc herniation, and scheduled for simple minimally invasive lumbar discectomy (e.g., endoscopic PTED/UBE or microdiscectomy MIS) according to routine clinical management. 3.Participants voluntarily sign the informed consent form and agree to participate in the study. 4.The study samples are remnant/discarded ex vivo nucleus pulposus tissue samples left over after excision during routine clinical care and no longer required for clinical diagnosis and treatment. 5.Basic clinical data and routine preoperative imaging data corresponding to the samples are available for research analysis. 6.After coding and de-identification, the samples can be used for EndoSCell scanning and corresponding paraffin pathology analysis.

Exclusion criteria

Exclusion criteria: 1.Concomitant obvious lumbar instability, spondylolisthesis, or requirement for fusion surgery. 2. History of previous lumbar surgery at the target level. 3.Severe osteoporosis (DXA T-score <= -3.5). 4.Concurrent spinal infection, tumor, fracture, or inflammatory disease. 5.Severe spinal deformity that may interfere with standardized intraoperative sample collection. 6.Pregnancy or lactation. 7.Judged by the investigator as unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Diagnostic performance and concordance of EndoSCell in evaluating degeneration of ex vivo nucleus pulposus tissue;

Secondary

MeasureTime frame
Agreement between ES-NDG grading and pathological grading (Kappa value);Distribution characteristics of nucleus pulposus degeneration among different testing units from the same case;Correlation between preoperative MRI Pfirrmann grading and EndoSCell grading or HE pathological grading;

Countries

China

Contacts

Public ContactFei Zou

Huashan Hospital, Fudan University

zillion-faculty@126.com+86 21 52887132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026